|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization on right-of-use asset | |||||
| Provision for credit losses | |||||
| Stock-based compensation | |||||
| Loss on reserves | |||||
| Impairment of assets | |||||
| Realized loss on marketable securities | |||||
| Amortization of premium and discount of marketable securities, net | |||||
| Change in fair value of derivative | |||||
| Change in fair value of common stock warrants liability | |||||
| Change in fair value of earnout liability | |||||
| Change in fair value of convertible notes | |||||
| Deferred tax provision | |||||
| Other non-cash expenses | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable net and other receivables | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Other long-term assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Payment on operating lease liabilities | |||||
| Operating lease liabilities | |||||
| Other liabilities, current | |||||
| Other liabilities, long-term | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| License prepayment within other long-term assets | |||||
| Purchases of property, plant, and equipment | |||||
| Proceeds from land held for sale | |||||
| Proceeds from sale of property, plant, and equipment | |||||
| Purchases of marketable securities | |||||
| Sales of marketable securities | |||||
| Maturities of marketable securities | |||||
| Capitalized interest on plant construction | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Payment of notes payable and other liabilities | |||||
| Proceeds from convertible notes | |||||
| Proceeds from Canadian Government Research and Development Program | |||||
| Proceeds from exercise of stock options | |||||
| Net cash provided by financing activities | |||||
| Effects of foreign exchange rate changes on the balance of cash and cash equivalents held in foreign currencies | |||||
| Net decrease in cash and cash equivalents | |||||
| Cash and cash equivalents beginning of the period | |||||
| Cash and cash equivalents end of the period | |||||
| Supplemental disclosure of cash flow information | |||||
| Operating lease ROU assets obtained in exchange for lease obligations | |||||
| Purchases of fixed assets included in accounts payable and accrued expenses | |||||
| Stock-based compensation capitalized into property, plant, and equipment | |||||
| Accrued interest capitalized into property, plant, and equipment | |||||
| Purchases of property, plant, and equipment included in notes payable | |||||
| Cash paid during the year | |||||
| Income taxes payment | |||||
| Interest payment | |||||
Loading...